Targeting of radionuclides with antibodies or radioimmunotherapy continues to be a Rabbit Polyclonal to APLF. dynamic field of analysis spanning nearly 50 years evolving with advancing technology in molecular biology and chemistry and numerous important preclinical and clinical research illustrating the huge benefits but also the issues which all types of targeted therapies encounter. studies… Continue reading Targeting of radionuclides with antibodies or radioimmunotherapy continues to be a